-+ 0.00%
-+ 0.00%
-+ 0.00%

Idorsia Launches Phase 2 Trial of Oral CCR6 Antagonist for Moderate-to-Severe Psoriasis

路透·01/06/2026 06:00:17

登录查看新闻详情